Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2020-08-07 17:10
Core Tip: According to the "2020 China Listed Companies Innovation Index Report" jointly released by Zhejiang University School of Management and Shenzhen Press Group Deep New Communication Think Tank on August 6, Beijing, Shenzhen, Shanghai, Hangzhou, Guangzhou, and Nanjing ranked among the top six cities in terms of innovation capability.
A domestic leader emerges in a 6 billion market! Healthy Yuan's inhaled budesonide is approved
Time Posted：2020-07-24 17:20
On July 22, 2020, Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Joincare")'s new inhaled preparation product, Wu Shu (Budesonide Suspension for Inhalation), was approved for marketing through the new Class 4 registration, becoming the first domestically produced small-specification budesonide to pass consistency evaluation! (Approval number: H20203343)
Time Posted：2020-07-23 17:15
Recently, the highly anticipated 2019 Top 100 Chinese Pharmaceutical Industry list was grandly released! Health Yuan (600380) Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Health Yuan"), with its solid R&D and production capabilities and steady market promotion capabilities, successfully entered the "2019 Top 100 Chinese Pharmaceutical Enterprises Ranking", a sub-list of the "2019 Top 100 Chinese Pharmaceutical Industry List", ranking Top 9!
Jiankang Yuan plans to introduce Hillhouse Capital to raise no more than 2.173 billion yuan.
Time Posted：2020-07-13 17:23
According to a press release issued by HealthGen on July 13th, the company plans to issue no more than 169,350,000 shares in a private placement to introduce Hillhouse Capital as a strategic investor. The total amount of funds raised is expected to not exceed 2.173 billion yuan. After the issuance, Hillhouse Capital's shareholding will account for 8% of HealthGen's total shares. HealthGen opened with a daily limit up today and closed at 18.37 yuan per share.
Time Posted：2020-07-10 17:22
The Shanghai Stock Exchange and the China Securities Index Co., Ltd. officially released the CSI Public Health Theme Index, the CSI Shanghai-Hong Kong-Shenzhen Mainland New Infrastructure Construction Theme Index, and the SSE New Infrastructure Construction Theme Index on July 7, 2020. Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Joincare") was selected as one of the constituent stocks of the CSI Public Health Theme Index due to its outstanding performance in public health environmental governance.
Levosalbutamol represents not only a change in name, but also a new direction.
Time Posted：2020-07-09 21:51
Time Posted：2020-06-22 19:47
According to the "Decision on Amending the Regulations on Environmental Protection Management of Construction Projects" (Order No. 682 of the State Council of the People's Republic of China) and the "Announcement on the Issuance of the Provisional Measures for the Acceptance of Environmental Protection upon Completion of Construction Projects" (Guohuan Guihuanping [2017] No. 4) and other relevant regulations, the "Completion Environmental Protection Acceptance Report of the Waste Liquid Comprehensive Recycling and Technological Upgrading Project of Jiaozuo Jiankangyuan Biopharmaceutical Co., Ltd." and the acceptance opinions are hereby submitted.
Time Posted：2020-06-09 19:47
Since the beginning of 2020, technology-related themes have remained a focus of investor attention and investment in the capital market. From pharmaceutical innovation and semiconductor chips to 5G communication and artificial intelligence, many high-tech fields have received relatively sustained market attention. Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan") has achieved outstanding performance in the greater health field, not only ranking among the constituent stocks of the CSI Technology 50 Strategy Index, but its stock price has also hit record highs in recent years.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.